| Literature DB >> 29611536 |
Tong Niu1, Chaoliang Lv1, Guangkun Yi1, Huamin Tang2, Cunji Gong3, Shizhen Niu4.
Abstract
BACKGROUND This study aimed to investigate the therapeutic effect of low, medium, and high concentrations of medical ozone on trauma-induced lumbar disc herniation. MATERIAL AND METHODS A total of 80 patients were included and were grouped into a control group, a low medical ozone (20 μg/ml) group, a medium medical ozone (40 μg/ml) group, and a high medical ozone (60 μg/ml) group. The CT scan and enzyme-linked immunosorbent assay (ELISA) were used to detect IL-6 level, SOD activity, IgM, and IgG levels upon admission and at 6 and 12 months after follow-up. The area under the ROC curve (AUC) was calculated for visual analogue scale (VAS) and efficiency rate. RESULTS All patients showed disc retraction at 6- and 12-month follow-up; while patients in the medium medical ozone (40 μg/ml) group showed the greatest disc retraction rate. The IL-6, IgM, IgG, and VAS levels significantly decreased while SOD activity increased among all groups over time (p<0.05). The AUCIL-6, AUCIgG, AUCIgM, and AUCSOD was closest to 1 in the medium medical ozone (40 μg/ml) group compared with other groups (p<0.01), with the highest efficacy at 6 (35%) and 12 (85%) months during follow-up. CONCLUSIONS Low concentrations of medical ozone (20 μg/ml and 40 μg/ml) reduced the serum IL-6, IgG, and IgM expression, presenting as analgesic and anti-inflammatory effects, while high concentrations of medical ozone (60 μg/ml) increased the serum IL-6, IgG, IgM expression, presenting as pain and pro-inflammatory effects. The medical ozone concentration of 40 μg/ml showed the optimal treatment efficacy.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29611536 PMCID: PMC5896688 DOI: 10.12659/msm.903243
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1CT images of Group A, Group B, Group C, and Group D. Upon admission, the intervertebral discs protruded; the intervertebral disc significantly retracted at 6-month follow-up; the intervertebral disc significantly retracted at 12-month follow-up.
The IL-6 levels in all groups (pg/ml, n=20).
| Upon admission | 6-month follow-up | 12-month follow-up | |
|---|---|---|---|
| Group A | 224.7±3.5 | 191.3±3.4 | 172.8±2.6 |
| Group B | 225.8±3.2 | 172.8±2.5 | 160.7±3.2 |
| Group C | 229.6±2.7 | 163.7±3.1 | 135.9±2.4 |
| Group D | 228.7±3.1 | 200.7±2.5 | 186.7±2.8 |
Compared with Group A,
P<0.05; compared with that upon admission,
P<0.05.
The IgM levels in all groups (mg/ml, n=20).
| Upon admission | 6-month follow-up | 12-month follow-up | |
|---|---|---|---|
| Group A | 2.73±1.25 | 2.05±1.41 | 1.86±1.61 |
| Group B | 2.65±1.22 | 1.89±1.21 | 1.71±1.11 |
| Group C | 2.62±1.12 | 1.34±1.21 | 1.17±1.04 |
| Group D | 2.71±1.31 | 2.27±1.21 | 1.93±1.38 |
Compared with Group A,
P<0.05; compared with that upon admission,
P<0.05.
The IgG levels in all groups (g/L, n=20).
| Upon admission | 6-month follow-up | 12-month follow-up | |
|---|---|---|---|
| Group A | 27.73±1.25 | 22.05±1.31 | 18.76±1.21 |
| Group B | 27.43±1.12 | 19.79±1.11 | 17.61±1.41 |
| Group C | 27.12±1.32 | 17.34±1.13 | 15.17±1.24 |
| Group D | 27.38±1.21 | 24.27±1.11 | 19.93±1.18 |
Compared with Group A,
P<0.05; compared with that upon admission,
P<0.05.
The SOD activity in all groups (g/L, n=20).
| Upon admission | 6-month follow-up | 12-month follow-up | |
|---|---|---|---|
| Group A | 97.73±1.15 | 132.05±1.31 | 156.76±1.21 |
| Group B | 99.43±1.21 | 152.29±1.11 | 170.61±1.41 |
| Group C | 98.12±1.12 | 162.14±1.13 | 192.17±1.24 |
| Group D | 99.38±1.21 | 110.27±1.11 | 149.93±1.18 |
Compared with Group A,
P<0.05; compared with that upon admission,
P<0.05.
Figure 2ROC curve analysis. (A) ROC curve of Group A. AUCIL-6: 0.557; AUCIgG: 0.582; AUCIgM: 0.504; AUCSOD: 0.314. (B) ROC curve of Group B. AUCIL-6: 0.396; AUCIgG: 0.268; AUCIgM: 0.139; AUCSOD: 0.296. (C) ROC curve of Group C. AUCIL-6: 0.754; AUCIgG: 0.886; AUCIgM: 0.878; AUCSOD: 0.986. (D) ROC curve of Group D. AUCIL-6: 0.270; AUC IgG: 0.238; AUC IgM: 0.468; AUCSOD: 0.393.
The VAS scores in all groups (points, n=20).
| Upon admission | 6-month follow-up | 12-month follow-up | |
|---|---|---|---|
| Group A | 8.76±1.23 | 6.05±1.21 | 4.66±1.22 |
| Group B | 8.63±1.24 | 4.79±1.11 | 3.31±1.41 |
| Group C | 8.72±1.42 | 3.34±1.14 | 2.17±1.24 |
| Group D | 8.58±1.31 | 5.37±1.21 | 3.93±1.16 |
Compared with Group A,
P<0.05; compared with that upon admission,
P<0.05.